Join us for dinner and learn about HEMGENIX: the first and only FDA-approved gene therapy for hemophilia B. HEMGENIX is a onetime gene therapy for treatment of adults with hemophilia B who currently use Factor IX prophylaxis therapy or have current or historical life-threatening bleeding or have repeated, serious spontaneous bleeding episodes. If you have hemophilia B or have someone in your family with hemophilia B, this is a great opportunity to learn more about HEMGENIX.
Event Speaker:
Richard Lemons, MD, PhD is the medical director and professor of pediatrics in the Division of Pediatric Hematology/Oncology at the University of Utah. Dr. Lemons received his medical degree from George Washington University School of Medicine in Washington, DC and completed a residency in pediatrics at Johns Hopkins Hospital, a fellowship in cancer biology research at the National Institutes of Health in Bethesda, Maryland, and a fellowship in tumor cell biology at St. Jude Children’s Research Hospital in Memphis, Tennessee. He also has a PhD degree in chemistry from Pennsylvania State University. He is currently a principal investigator for several clinical studies related to pediatric malignancies and pediatric investigator for several clinical studies related to pediatric malignancies and pediatric hematologic disorders, including a gene therapy study for hemophilia B.
Program Information:
Date: Tuesday, September 19, 2023
Time: 6:00 PM – 8:00 PM
Location:
Sullivan’s Steakhouse
1785 E River Rd
Tucson, AZ 85718
.
